UBE2T and hepatocellular carcinoma: The latest research shows that ubiquitin-conjugating enzyme E2T(UBE2T) increases pyrimidine metabolism by promoting the ubiquitination of Akt Lys63 connection, thus contributing to the occurrence and development of hepatocellular carcinoma [184].